zum Directory-modus

Krankheiten des Nervensystems

Literatur zur Alzheimer-Krankheit

Literatur

Babic, T. (1999): The cholinergic hypothesis of Alzheimer's disease: a review of progress. In: J. Neurol. Neurosurg. Psychiatry. 67 , 558
Blusztajn, J. K.; Berse, B. (2000): The cholinergic neuronal phenotype in Alzheimer's disease. In: Metab. Brain Dis.. 15 , 45-64
Braak, E.; Griffing, K.; Arai, K.; Bohl , J.; Bratzke, H.; Braak, H. (1999): Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?. In: Eur. Arch. Psychiatry Clin. Neurosci.. 249 , 14-22
Chen, G.; Chen, K. S.; Knox, J.; Inglis, J.; Bernard, A.; Martin, S. J.; Justice, A.; McConlogue, L.; Games, D.; Freedman, S. B.; Morris, R. G. (2000): A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. In: Nature. 408 , 975-979
Chorsky, R. L.; Yaghmai, F.; Hill, W. D.; Stopa, E. G. (2001): Alzheimer's disease: a review concerning immune response and microischemia. In: Med. Hypotheses. 56 , 124-127
Dinsmore, S. T. (1999): Treatment options for Alzheimer's disease. In: J. Am. Osteopath. Assoc.. 99 , S6-S8
Dovey, H. F.; John, V.; Anderson, J. P.; Chen, L. Z.; de Saint Andrieu, P.; Fang, L. Y.; Freedman, S. B.; Folmer, B.; Goldbach, E.; Holsztynska, E. J.; Hu, K. L.; Johnson-Wood, K. L.; Kennedy, S. L.; Kholodenko, D.; Knops, J. E.; Latimer, L. H.; Lee, M.; Liao, Z.; Lieberburg, I. M.; Motter, R. M.; Mutter, L. C.; Nietz, J.; Quinn, K. P.; Sacchi, K. L.; Seubert, P. A.; Shopp, G. M.; Thorsett, E. D.; Tung, J. S.; Wu, J.; Yang, S.; Yin, C. T.; Schenk, D. B.; May, P. C.; Altstiel, L. D.; Bender, M. H.; Boggs, L. N.; Britton, T. C.; Clemens, J. C.; Czilli , D. L.; Dieckman-McGinty, D. K.; Droste, J. J.; Fuson, K. S.; Gitter, B. D.; Hyslop, P. A.; Johnstone, E. M.; Li, W. Y.; Little, S. P.; Mabry, T. E.; Miller, F. D.; Audia, J. E. (2001): Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. In: J. Neurochem.. 76 , 173-181
Duda, J. E.; Lee, V. M.; Trojanowski, J. Q. (2000): Neuropathology of synuclein aggregates. In: J. Neurosci. Res.. 61 , 121-127
Felician,, O.; Sandson, T. A. (1999): The neurobiology and pharmacotherapy of Alzheimer's disease. In: J. Neuropsychiatry Clin. Neurosci.. 11 , 19-31
Francis, P. T.; Palmer, A. M.; Snape, M.; Wilcock , G. K. (1999): The cholinergic hypothesis of Alzheimer's disease: a review of progress. In: J. Neurol. Neurosurg. Psychiatry. 66 , 137-147
Frenkel, D.; Katz, O.; Solomon, B. (2000): Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration. In: Proc. Natl. Acad. Sci.USA. 97 , 11455-11459
Gottwald, M. D.; Rozanski, R. I. (1999): Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status. In: Expert. Opin. Investig. Drugs. 8 , 1673-1682
Grundman, M.; Thal, L. J. (2000): Treatment of Alzheimer's disease: rationale and strategies. In: Neurol. Clin.. 18 , 807-828
Harkany, T.; Abraham, I.; Konya, C.; Nyakas, C.; Zarandi, M.; Penke, B.; Luiten, P. G. (2000): Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy. In: Rev. .Neurosci.. 11 , 329-382
Heininger, K. (2000): A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events. In: Rev. Neurosci.. 11 , 213-328
Janus, C.; Pearson, J.; McLaurin, J.; Mathews, P. M.; Jiang, Y.; Schmidt, S. D.; Chishti, M. A.; Horne, P.; Heslin, D.; French, J.; Mount, H. T.; Nixon, R. A.; Mercken, M.; Bergeron, C.; Fraser, S.; George-Hyslop, P.; Westaway, D. (2000): A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. In: Nature. 408 , 979-982
Kawahara, M.; Kuroda, Y. (2000): Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. In: Brain Res. Bull.. 53 , 389-397
Lorenzo, A.; Yuan, M.; Zhang, Z.; Paganetti, P. A.; Sturchler-Pierrat, C.; Staufenbiel, M.; Mautino, J.; Vigo, F. S.; Sommer, B.; Yankner, B. A. (2000): Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. In: Nat. Neurosci.. 3 , 460-464
Lukiw, W. J.; Bazan, N. G. (2000): Neuroinflammatory signaling upregulation in Alzheimer's disease. In: Neurochem. Res.. 25 , 1173-1184
Maelicke, A.; Schrattenholz, A. (2000): Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. In: Behav. Brain Res.. 113 , 199-206
Maelicke, A. (2000): Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease. In: Dement. Geriatr. Cogn. Disord.. 11 , 11-18
Maelicke, A.; Samochocki, M.; Jostock, R.; Fehrenbacher, A.; Ludwig, J.; Albuquerque, E. X.; Zerlin, M. (2001): Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. In: Biol. Psychiatry. 49 , 279-288
Maier-Lorentz, M. M. (2000): Neurobiological bases for Alzheimer's disease. In: J. Neurosci. Nurs.. 32 , 117-125
Morgan, D.; Diamond, D.; Gottschall, P. E.; Ugen, K. E.; Dickey, C.; Hardy, J.; Duff, K.; Jantzen, P.; DiCarlo, G.; Wilcock, D.; Connor, K.; Hatcher, J.; Hope, C.; Gordon, M.; Arendash, G. W. (2000): A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. In: Nature. 408 , 982-985
Perl, D. P. (2000): Neuropathology of Alzheimer's disease and related disorders. In: Neurol. Clin.. 18 , 847-864
Pettegrew, J. W.; Klunk, W. E.; Panchalingam, K.; McClure, R. J.; Stanley, J. A. (2000): Molecular insights into neurodevelopmental and neurodegenerative diseases. In: Brain Res. Bull. 53 , 455-469
Thorsett, E. D.; Latimer, L. H. (2000): Therapeutic approaches to Alzheimer's disease. In: Curr. Opin. Chem. Biol.. 4 , 377-382
Wevers, A.; Witter, B.; Moser, N.; Burghaus, L.; Banerjee, C.; Steinlein, O. K.; Schutz, U.; de Vos, R. A.; Steur, E. N.; Lindstrom, J.; Schroder, H. (2000): Classical Alzheimer features and cholinergic dysfunction: towards a unifying hypothesis?. In: Acta Neurol. Scand. Suppl.. 176 , 42-48
Younkin, S. G. (2001): Amyloid beta vaccination: reduced plaques and improved cognition. In: Nat. Med.. 7 , 18-19
Yuan, J.; Yankner, B. A. (2000): Apoptosis in the nervous system. In: Nature. 407 , 802-809

Zugang zur PubMed-Datenbank

Seite 9 von 9>